Influenza Virus and SARS-CoV-2 Vaccines

被引：13
作者：
Sandor, Adam M. [1 ,2 ,3 ,4 ]
Sturdivant, Michael S. [1 ,5 ]
Ting, Jenny P. Y. [1 ,2 ,3 ]
机构：
[1] Univ North Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[2] Univ North Carolina, Dept Genet, Chapel Hill, NC 27599 USA
[3] Univ North Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA
[4] Univ North Carolina, Div Pharmacoengn & Mol Pharmaceut, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA
[5] Univ North Carolina, Biol & Biomed Sci Program, Chapel Hill, NC 27599 USA
来源：
JOURNAL OF IMMUNOLOGY | 2021年 / 206卷 / 11期
关键词：
NEUTRALIZING MONOCLONAL-ANTIBODIES; GUILLAIN-BARRE-SYNDROME; SEASONAL INFLUENZA; H1N1; INFLUENZA; DENDRITIC CELLS; PANDEMIC PREPAREDNESS; DEPENDENT ENHANCEMENT; AFFINITY MATURATION; ADAPTIVE IMMUNITY; B-CELLS;
D O I：
10.4049/jimmunol.2001287
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Seasonal influenza and the current COVID-19 pandemic represent looming global health challenges. Efficacious and safe vaccines remain the frontline tools for mitigating both influenza virus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced diseases. This review will discuss the existing strategies for influenza vaccines and how these strategies have informed SARS-CoV-2 vaccines. It will also discuss new vaccine platforms and potential challenges for both viruses.
引用
收藏
页码：2509 / 2520
页数：12
相关论文
共 236 条
[11]   Practical review of immunizations in adult patients with cancer [J].
Ariza-Heredia, Ella J. ;
Chemaly, Roy F. .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (11) :2606-2614
[12]   Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study [J].
Assiri, Abdullah ;
Al-Tawfiq, Jaffar A. ;
Al-Rabeeah, Abdullah A. ;
Al-Rabiah, Fahad A. ;
Al-Hajjar, Sami ;
Al-Barrak, Ali ;
Flemban, Hesham ;
Al-Nassir, Wafa N. ;
Balkhy, Hanan H. ;
Al-Hakeem, Rafat F. ;
Makhdoom, Hatem Q. ;
Zumla, Alimuddin I. ;
Memish, Ziad A. .
LANCET INFECTIOUS DISEASES, 2013, 13 (09) :752-761
[13]   In Vitro Analysis of Acetalated Dextran Microparticles as a Potent Delivery Platform for Vaccine Adjuvants [J].
Bachelder, Eric M. ;
Beaudette, Tristan T. ;
Broaders, Kyle E. ;
Frechet, Jean M. J. ;
Albrecht, Mark T. ;
Mateczun, Alfred J. ;
Ainslie, Kristy M. ;
Pesce, John T. ;
Keane-Myers, Andrea M. .
MOLECULAR PHARMACEUTICS, 2010, 7 (03) :826-835
[14]   Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine [J].
Baden, Lindsey R. ;
El Sahly, Hana M. ;
Essink, Brandon ;
Kotloff, Karen ;
Frey, Sharon ;
Novak, Rick ;
Diemert, David ;
Spector, Stephen A. ;
Rouphael, Nadine ;
Creech, C. Buddy ;
McGettigan, John ;
Khetan, Shishir ;
Segall, Nathan ;
Solis, Joel ;
Brosz, Adam ;
Fierro, Carlos ;
Schwartz, Howard ;
Neuzil, Kathleen ;
Corey, Larry ;
Gilbert, Peter ;
Janes, Holly ;
Follmann, Dean ;
Marovich, Mary ;
Mascola, John ;
Polakowski, Laura ;
Ledgerwood, Julie ;
Graham, Barney S. ;
Bennett, Hamilton ;
Pajon, Rolando ;
Knightly, Conor ;
Leav, Brett ;
Deng, Weiping ;
Zhou, Honghong ;
Han, Shu ;
Ivarsson, Melanie ;
Miller, Jacqueline ;
Zaks, Tal .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) :403-416
[15]   Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses [J].
Barrett, Jordan R. ;
Belij-Rammerstorfer, Sandra ;
Dold, Christina ;
Ewer, Katie J. ;
Folegatti, Pedro M. ;
Gilbride, Ciaran ;
Halkerston, Rachel ;
Hill, Jennifer ;
Jenkin, Daniel ;
Stockdale, Lisa ;
Verheul, Marije K. ;
Aley, Parvinder K. ;
Angus, Brian ;
Bellamy, Duncan ;
Berrie, Eleanor ;
Bibi, Sagida ;
Bittaye, Mustapha ;
Carroll, Miles W. ;
Cavell, Breeze ;
Clutterbuck, Elizabeth A. ;
Edwards, Nick ;
Flaxman, Amy ;
Fuskova, Michelle ;
Gorringe, Andrew ;
Hallis, Bassam ;
Kerridge, Simon ;
Lawrie, Alison M. ;
Linder, Aline ;
Liu, Xinxue ;
Madhavan, Meera ;
Makinson, Rebecca ;
Mellors, Jack ;
Minassian, Angela ;
Moore, Maria ;
Mujadidi, Yama ;
Plested, Emma ;
Poulton, Ian ;
Ramasamy, Maheshi N. ;
Robinson, Hannah ;
Rollier, Christine S. ;
Song, Rinn ;
Snape, Matthew D. ;
Tarrant, Richard ;
Taylor, Stephen ;
Thomas, Kelly M. ;
Voysey, Merryn ;
Watson, Marion E. E. ;
Wright, Daniel ;
Douglas, Alexander D. ;
Green, Catherine M. .
NATURE MEDICINE, 2021, 27 (02) :279-+
[16]  
Basta N, 2020, COVID-19 vaccine development and approvals tracker
[17]  
Batty Cole J., 2018, Pharmaceutical Nanotechnology, V6, P232, DOI 10.2174/2211738506666180918122337
[18]   Assessing the pandemic potential of MERS-CoV [J].
Bauch, Chris T. ;
Oraby, Tamer .
LANCET, 2013, 382 (9893) :662-664
[19]  
Bell D, 2006, EMERG INFECT DIS, V12, P81
[20]   Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies [J].
Belongia, Edward A. ;
Simpson, Melissa D. ;
King, Jennifer P. ;
Sundaram, Maria E. ;
Kelley, Nicholas S. ;
Osterholm, Michael T. ;
McLean, Huong Q. .
LANCET INFECTIOUS DISEASES, 2016, 16 (08) :942-951
12345678910